INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 48m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

CAPRCAPRICOR THERAPEUTICS, INC.

CIK 0001133869

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 2
Max Insider Score26
Connections7with evidence

CAPR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MT
Maurer Michael TCHIEF COMMERCIAL OFFICER
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
80.0K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    CHECKMATE GOVERNMENT RELATIONSLDA RR 2026 third quarter · Health issues · Sep 3, 2026
  • ← Insider ofevidence
    Maurer Michael TCHIEF COMMERCIAL OFFICER · May 28, 2026
  • ← Insider ofevidence
    Kelliher MikeDirector · Jan 7, 2026
5
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M
$298K
61.3K sh
Mar 31, 2026
Apr 1, 2026
traded Mar 31, 2026
+1d
SEC FORM 4

Evidence

26
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.85M
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

1
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$261K
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
1,360 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
5,420 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
GJ
Gotwals Philip JDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Sabar Karimah EsDirector · Jan 7, 2026
  • ← Insider ofevidence
    Auwaerter Paul GisbertDirector · Jan 7, 2026
  • ← Insider ofevidence
    Gotwals Philip JDirector · Jan 7, 2026

    • Lobbying

    $0 reported · de-duplicated
    2026 Q3 $0 via firms
    • CHECKMATE GOVERNMENT RELATIONS—2026 Q3 · posted Sep 3, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.